Spatial-temporal protein expression of inhibitor of differentiation-1 (Id1) during fetal embryogenesis and in different mouse and human cancer types

Histology and Histopathology

Volumn 28, Issue 8, 2013, Pages 1029-1040

  Redrado, Miriam ^a   Bodegas, Elena ^b   Villaro, Ana Cristina ^b   Nguewa, Paul A ^a   Lopez, Ines ^a   Gil Bazo, Ignacio ^a   Calvo, Alfonso ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Histocore (H score); Inhibitor of differentiation 1 (ID1); Mouse embryonic development; Squamous cell carcinomas; Tissue MicroArray (TMA)

Indexed keywords

ID1 PROTEIN, HUMAN; IDB1 PROTEIN, MOUSE; INHIBITOR OF DIFFERENTIATION 1; MONOCLONAL ANTIBODY;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CANCER TRANSPLANTATION; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROARRAY ANALYSIS; MOUSE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TIME; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, TRANSGENIC; MICROARRAY ANALYSIS; NEOPLASM TRANSPLANTATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84880443642     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Ariel I., de Groot N. and Hochberg A. (2000). Imprinted h19 gene expression in embryogenesis and human cancer: The oncofetal connection. Am. J. Med. Genet. 91, 46-50.
2. Barrett L.E., Granot Z., Coker C., Iavarone A., Hambardzumyan D., Holland E.C., Nam H.S. and Benezra R. (2012). Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell 21, 11-24.
3. Benezra R., Davis R.L., Lockshon D., Turner D.L. and Weintraub H. (1990). The protein id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
4. Benezra R., Rafii S. and Lyden D. (2001). The id proteins and angiogenesis. Oncogene 20, 8334-8341.
5. Bianco C., Strizzi L., Normanno N., Khan N. and Salomon D.S. (2005). Cripto-1: An oncofetal gene with many faces. Curr. Top. Dev. Biol. 67, 85-133.
6. Calvo R. and Drabkin H.A. (2000). Embryonic genes in cancer. Ann. Oncol. 11 Suppl. 3, 207-218.
7. Calvo A., Xiao N., Kang J., Best C.J., Leiva I., Emmert-Buck M.R., Jorcyk C. and Green J.E. (2002). Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-p in mouse and human tumors. Cancer Res. 62, 5325-5335.
8. Calvo A., Catena R., Noble M.S., Carbott D., Gil-Bazo I., Gonzalez-Moreno O., Huh J.I., Sharp R., Qiu T.H., Anver M.R., Merlino G., Dickson R.B., Johnson M.D. and Green J.E. (2008). Identification of vegf-regulated genes associated with increased lung metastatic potential: Functional involvement of tenascin-c in tumor growth and lung metastasis. Oncogene 27, 5373-5384.
9. Cooper C.L., Brady G., Bilia F., Iscove N.N. and Quesenberry P.J. (1997). Expression of the id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood 89, 3155-3165.
10. Coppe J.P., Itahana Y., Moore D.H., Bennington J.L. and Desprez P.Y. (2004). Id-1 and id-2 proteins as molecular markers for human prostate cancer progression. Clin. Cancer Res. 10, 2044-2051.
11. Chen Y. and Olopade O.I. (2008). Myc in breast tumor progression. Expert. Rev. Anticancer Ther. 8, 1689-1698.
12. Cheung P.Y., Yip Y.L., Tsao S.W., Ching Y.P. and Cheung A.L. (2011). Id-1 induces cell invasiveness in immortalized epithelial cells by regulating cadherin switching and rho gtpases. J. Cell. Biochem. 112, 157-168.
13. de Candia P., Benezra R. and Solit D.B. (2004). A role for id proteins in mammary gland physiology and tumorigenesis. Adv. Cancer Res. 92, 81-94.
14. Dong Z., Liu S., Zhou C., Sumida T., Hamakawa H., Chen Z., Liu P. and Wei F. (2010). Overexpression of id-1 is associated with tumor angiogenesis and poor clinical outcome in oral squamous cell carcinoma. Oral Oncol. 46, 154-157.
15. Endo-Munoz L., Cumming A., Sommerville S., Dickinson I. and Saunders N.A. (2010). Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. Br. J. Cancer 103, 73-81.
16. Fong S., Itahana Y., Sumida T., Singh J., Coppe J.P., Liu Y., Richards P.C., Bennington J.L., Lee N.M., Debs R.J. and Desprez P.Y. (2003). Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. USA 100, 13543-13548.
17. Fong S., Debs R.J. and Desprez P.Y. (2004). Id genes and proteins as promising targets in cancer therapy. Trends Mol. Med. 10, 387-392.
18. Forootan S.S., Wong Y.C., Dodson A., Wang X., Lin K., Smith P.H., Foster C.S. and Ke Y. (2007). Increased id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum. Pathol. 38, 1321-1329.
19. Gingrich J.R., Barrios R.J., Morton R.A., Boyce B.F., DeMayo F.J., Finegold M.J., Angelopoulou R., Rosen J.M. and Greenberg N.M. (1996). Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56, 4096-4102.
20. Gupta G.P., Perk J., Acharyya S., de Candia P., Mittal V., Todorova-Manova K., Gerald W.L., Brogi E., Benezra R. and Massague J. (2007). Id genes mediate tumor reinitiation during breast cancer lung metastasis. Proc. Natl. Acad. Sci. USA 104, 19506-19511.
21. Hau P.M., Tsang C.M., Yip Y.L., Huen M.S. and Tsao S.W. (2011). Id1 interacts and stabilizes the epstein-barr virus latent membrane protein 1 (lmp1) in nasopharyngeal epithelial cells. PLoS One 6, e21176.
22. Henke E., Perk J., Vider J., de Candia P., Chin Y., Solit D.B., Ponomarev V., Cartegni L., Manova K., Rosen N. and Benezra R. (2008). Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo. Nat. Biotechnol. 26, 91-100.
23. Hida Y. and Hamada J.I. (2012). Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers. Anticancer Agents Med. Chem. 12,744-752.
24. Huang L., Wang H., Yu Y., Guo R.W., Shi Y.K., Song M.B., Chen J.F., Yu S.Y., Yin Y.G. and Gao P. (2010). Inhibitor of DNA binding-1 promotes the migration and proliferation of endothelial progenitor cells in vitro. Mol. Cell. Biochem. 335, 19-27.
25. Huh J.I., Calvo A., Charles R. and Green J.E. (2006). Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with id-1 expression. Cancer Res. 66, 3495-3503.
26. Jankiewicz M., Groner B. and Desrivieres S. (2006). Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding id1 and their functional differentiation through id2. Mol. Endocrinol. 20, 2369-2381.
27. Jankovic V., Ciarrocchi A., Boccuni P., DeBlasio T., Benezra R. and Nimer S.D. (2007). Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 104, 1260-1265.
28. Jen Y., Manova K. and Benezra R. (1997). Each member of the id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 208, 92-106.
29. Kamalian L., Gosney J.R., Forootan S.S., Foster C.S., Bao Z.Z., Beesley C. and Ke Y. (2008). Increased expression of id family proteins in small cell lung cancer and its prognostic significance. Clin. Cancer Res. 14, 2318-2325.
30. Lin C.Q., Parrinello S., Campisi J. and Desprez P.Y. (1999). Regulation of mammary epithelial cell phenotypes by the helix-loop-helix protein, id-1. Endocr. Relat. Cancer. 6, 49-50.
31. Ling M.T., Wang X., Zhang X. and Wong Y.C. (2006). The multiple roles of id-1 in cancer progression. Differentiation 74, 481-487.
32. Lowery J.W., Frump A.L., Anderson L., DiCarlo G.E., Jones M.T. and de Caestecker M.P. (2010). Id family protein expression and regulation in hypoxic pulmonary hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1463-1477.
33. Lyden D., Young A.Z., Zagzag D., Yan W., Gerald W., O'Reilly R., Bader B.L., Hynes R.O., Zhuang Y., Manova K. and Benezra R. (1999). Id1 and id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677.
34. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R. and Rafii S. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201.
35. Meteoglu I., Meydan N. and Erkus M. (2008). Id-1: Regulator of egfr and vegf and potential target for colorectal cancer therapy. J. Exp. Clin. Cancer Res. 27, 69.
36. Monk M. and Holding C. (2001). Human embryonic genes re-expressed in cancer cells. Oncogene 20, 8085-8091.
37. Nam H.S. and Benezra R. (2009). High levels of id1 expression define b1 type adult neural stem cells. Cell Stem Cell 5, 515-526.
38. Nishimine M., Nakamura M., Mishima K., Kishi M., Kirita T., Sugimura M. and Konishi N. (2003). Id proteins are overexpressed in human oral squamous cell carcinomas. J. Oral. Pathol. Med. 32, 350-357.
39. Pajares M.J., Zudaire I., Lozano M.D., Agorreta J., Bastarrika G., Torre W., Remirez A., Pio R., Zulueta J.J. and Montuenga L.M. (2006). Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features. Cancer Epidem. Biomar. 15, 373-380.
40. Pajares M.J., Agorreta J., Larrayoz M., Vesin A., Ezponda T., Zudaire I., Torre W., Lozano M.D., Brambilla E., Brambilla C., Wistuba, II, Behrens C., Timsit J.F., Pio R., Field J.K. and Montuenga L.M. (2012). Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. J. Clin. Oncol. 30, 1129-1136.
41. Perk J., Iavarone A. and Benezra R. (2005). Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603-614.
42. Perk J., Gil-Bazo I., Chin Y., de Candia P., Chen J.J., Zhao Y., Chao S., Cheong W., Ke Y., Al-Ahmadie H., Gerald W.L., Brogi E. and Benezra R. (2006). Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res. 66, 10870-10877.
43. Pietilainen T., Lipponen P., Aaltomaa S., Eskelinen M., Kosma V.M. and Syrjanen K. (1995). Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res. 15, 959-964.
44. Pillai S., Rizwani W., Li X., Rawal B., Nair S., Schell M.J., Bepler G., Haura E., Coppola D. and Chellappan S. (2011). Id1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol. Cell. Biol. 31, 3052-3067.
45. Ponz-Sarvise M., Nguewa P.A., Pajares M.J., Agorreta J., Lozano M.D., Redrado M., Pio R., Behrens C., Wistuba, II, Garcia-Franco C.E., Garcia-Foncillas J., Montuenga L.M., Calvo A. and Gil-Bazo I. (2011). Inhibitor of differentiation-1 as a novel prognostic factor in nsclc patients with adenocarcinoma histology and its potential contribution to therapy resistance. Clin. Cancer Res. 17, 4155-4166.
46. Rehm S., Ward J.M., Anderson L.M., Riggs C.W. and Rice J.M. (1991). Transplacental induction of mouse lung tumors: Stage of fetal organogenesis in relation to frequency, morphology, size, and neoplastic progression of n-nitrosoethylurea-induced tumors. Toxicol. Pathol. 19, 35-46.
47. Romero-Lanman E.E., Pavlovic S., Amlani B., Chin Y. and Benezra R. (2012). Id1 maintains embryonic stem cell self-renewal by upregulation of nanog and repression of brachyury expression. Stem Cells Dev. 21, 384-393.
48. Rothschild S.I., Tschan M.P., Federzoni E.A., Jaggi R., Fey M.F., Gugger M. and Gautschi O. (2012). Microrna-29b is involved in the src-id1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene 31,4221-4232.
49. Ruzinova M.B. and Benezra R. (2003). Id proteins in development, cell cycle and cancer. Trends Cell. Biol. 13, 410-418.
50. Schoppmann S.F., Schindl M., Bayer G., Aumayr K., Dienes J., Horvat R., Rudas M., Gnant M., Jakesz R. and Birner P. (2003). Overexpression of id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104, 677-682.
51. Strizzi L., Bianco C., Normanno N. and Salomon D. (2005). Cripto-1: A multifunctional modulator during embryogenesis and oncogenesis. Oncogene 24, 5731-5741.
52. Swarbrick A., Akerfeldt M.C., Lee C.S., Sergio C.M., Caldon C.E., Hunter L.J., Sutherland R.L. and Musgrove E.A. (2005). Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein id1. Oncogene 24, 381-389.
53. Tobin N.P., Sims A.H., Lundgren K.L., Lehn S. and Landberg G. (2011). Cyclin d1, id1 and emt in breast cancer. BMC Cancer 11, 417.
54. Wang Y., Benezra R. and Sassoon D.A. (1992). Id expression during mouse development: A role in morphogenesis. Dev. Dyn. 194, 222-230.
55. Wang Z.F., Stein R., Sharkey R.M. and Goldenberg D.M. (1990). Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model. Cancer Res. 50, 869s-872s.
56. Wong Y.C., Wang X. and Ling M.T. (2004). Id-1 expression and cell survival. Apoptosis 9, 279-289.
57. Xi L., Nicastri D.G., El-Hefnawy T., Hughes S.J., Luketich J.D. and Godfrey T.E. (2007). Optimal markers for real-time quantitative reverse transcription pcr detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin. Chem. 53, 1206-1215.
58. Xu J., Chen Y. and Olopade O.I. (2010). Myc and breast cancer. Genes Cancer 1, 629-640.
59. Yakovlev A.Y. and Pavlova L.V. (1997). Mechanistic modeling of multiple tumorigenesis: An application to data on lung tumors in mice exposed to urethane. Ann. N. Y. Acad. Sci. 837, 462-468.
60. Yang S.Z., Dong J.H., Li K., Zhang Y. and Zhu J. (2005). Detection of afpmrna and melanoma antigen gene-1mrna as markers of disseminated hepatocellular carcinoma cells in blood. Hepatobiliary Pancreat. Dis. Int. 4, 227-233.
61. Zebedee Z. and Hara E. (2001). Id proteins in cell cycle control and cellular senescence. Oncogene 20, 8317-8325.
62. Zhang B., Halder S.K., Kashikar N.D., Cho Y.J., Datta A., Gorden D.L. and Datta P.K. (2010). Antimetastatic role of smad4 signaling in colorectal cancer. Gastroenterology 138, 969-980 e961-963.